| scholarly article | Q13442814 |
| editorial | Q871232 |
| P356 | DOI | 10.1210/EN.139.6.2659 |
| P698 | PubMed publication ID | 9607769 |
| P2093 | author name string | Pacifici R | |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | osteoporosis | Q165328 |
| estrogen | Q277954 | ||
| P304 | page(s) | 2659-2661 | |
| P577 | publication date | 1998-06-01 | |
| P1433 | published in | Endocrinology | Q3054009 |
| P1476 | title | Cytokines, estrogen, and postmenopausal osteoporosis--the second decade | |
| P478 | volume | 139 |
| Q36339797 | Analysis of the associations among Helicobacter pylori infection, adiponectin, leptin, and 10-year fracture risk using the fracture risk assessment tool: A cross-sectional community-based study. |
| Q36452858 | Aromatase inhibitor treatment for breast cancer: short-term effect on bone health |
| Q37602954 | Association between postmenopausal osteoporosis and experimental periodontitis |
| Q33635581 | Associations between endogenous sex hormone levels and mammographic and bone densities in premenopausal women |
| Q28361888 | Attenuation of the self-renewal of transit-amplifying osteoblast progenitors in the murine bone marrow by 17 beta-estradiol |
| Q33734897 | Bone phenotypes in response to gonadotropin misexpression: the role for gonadotropins in postmenopausal osteoporosis |
| Q37029020 | Bone selective protective effect of a novel bone-seeking estrogen on trabecular bone in ovariectomized rats |
| Q34495146 | CCR2 elimination in mice results in larger and stronger tibial bones but bone loss is not attenuated following ovariectomy or muscle denervation. |
| Q92464667 | Chronic hyponatremia in patients with proximal femoral fractures after low energy trauma: A retrospective study in a level-1 trauma center |
| Q37105442 | Correlates of bone quality in older persons. |
| Q51748022 | Cross-sex pattern of bone mineral density in early onset gender identity disorder. |
| Q28295303 | Disorders of Bone Remodeling |
| Q38831813 | ENPP1 and ESR1 genotypes influence temporomandibular disorders development and surgical treatment response in dentofacial deformities. |
| Q43777181 | Effect of mechanical stretch on the proliferation and differentiation of BMSCs from ovariectomized rats |
| Q36556179 | Effects of 8-Prenylnaringenin and Whole-Body Vibration Therapy on a Rat Model of Osteopenia |
| Q47138639 | Effects of Salvia miltiorrhiza extract with supplemental liquefied calcium on osteoporosis in calcium-deficient ovariectomized mice |
| Q41608833 | Effects of prenatal exposure to alcohol on the release of adenocorticotropic hormone, corticosterone, and proinflammatory cytokines |
| Q47790624 | Estrogen Deficiency Exacerbates Type 1 Diabetes-Induced Bone TNF-α Expression and Osteoporosis in Female Mice. |
| Q37271202 | Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha |
| Q28251201 | Estrogen regulation of immune cell bone interactions |
| Q33854310 | Estrogen's bone-protective effects may involve differential IL-1 receptor regulation in human osteoclast-like cells |
| Q91945053 | Freeze-Dried Watermelon Supplementation Has Modest Effects on Bone and Lipid Parameters of Ovariectomized Mice |
| Q34749500 | Genetics of osteoporosis: role of steroid hormone receptor gene polymorphisms. |
| Q73778137 | Impaired estrogen sensitivity in bone by inhibiting both estrogen receptor alpha and beta pathways |
| Q49194868 | In vitro cell behaviors of bone mesenchymal stem cells derived from normal and postmenopausal osteoporotic rats |
| Q38169799 | Influence of sex steroids on inflammation and bone metabolism |
| Q40176486 | Is centrally induced alveolar bone loss in a large animal model preventable by peripheral hormone substitution? |
| Q36274936 | Management of arthralgias associated with aromatase inhibitor therapy |
| Q33692675 | Modulation by cytokines of glucocorticoid action. |
| Q35939914 | Molecular basis of requirement of receptor activator of nuclear factor κB signaling for interleukin 1-mediated osteoclastogenesis. |
| Q35990478 | Multifactorial analysis of risk factors for reduced bone mineral density among postmenopausal women |
| Q37777428 | Neuropeptide Y and osteoblast differentiation--the balance between the neuro-osteogenic network and local control |
| Q42831731 | Neuropeptide Y expression and function during osteoblast differentiation--insights from transthyretin knockout mice |
| Q35755039 | Osteoclasts: New Insights |
| Q36602669 | Periodontal disease and systemic conditions: a bidirectional relationship. |
| Q38327712 | Platelet-derived growth factor induces interleukin-6 transcription in osteoblasts through the activator protein-1 complex and activating transcription factor-2. |
| Q46500936 | Prevalence of Helicobacter pylori infection in male patients with osteoporosis and controls |
| Q55281007 | Relationship between Helicobacter pylori infection and bone mineral density: a retrospective cross-sectional study. |
| Q78049289 | Required and nonessential functions of nuclear factor-kappa B in bone cells |
| Q39607279 | Resveratrol-mediated SIRT-1 interactions with p300 modulate receptor activator of NF-kappaB ligand (RANKL) activation of NF-kappaB signaling and inhibit osteoclastogenesis in bone-derived cells |
| Q36995896 | Rhus javanica Gall Extract Inhibits the Differentiation of Bone Marrow-Derived Osteoclasts and Ovariectomy-Induced Bone Loss |
| Q34065648 | Selected markers of bone biochemistry |
| Q34090842 | Selective targeting of RANK signaling pathways as new therapeutic strategies for osteoporosis. |
| Q36093022 | The IVVY Motif and Tumor Necrosis Factor Receptor-associated Factor (TRAF) Sites in the Cytoplasmic Domain of the Receptor Activator of Nuclear Factor κB (RANK) Cooperate to Induce Osteoclastogenesis |
| Q33849962 | The Relationship between H. pylori Infection and Osteoporosis in Japan |
| Q51560357 | The effects of native and synthetic estrogenic compounds as well as vitamin D less-calcemic analogs on adipocytes content in rat bone marrow. |
| Q87249625 | The effects of α-zearalanol on the proliferation of bone-marrow-derived mesenchymal stem cells and their differentiation into osteoblasts |
| Q34143343 | The immune system and bone |
| Q36324949 | The role of T lymphocytes in bone metabolism |
| Q38314616 | Transforming growth factor-beta increases interleukin-6 transcripts in osteoblasts |
| Q33950241 | Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo |
Search more.